“immunotherapy” Archives

in
Entry Author Date Location
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
New Bluebird Data Hint at Gene Therapy’s Limits For Some Patients 11/05/15 Boston
Evelo Launches With $35M To Fight Cancer With Cocktails of Bacteria 11/04/15 Boston
With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz 10/22/15 Boston
Texas Roundup: RunTitle, BioHouston, Civitas, OncoReponse, DNAtrix 10/06/15 Texas
Houston’s M.D. Anderson, Theraclone Launch Immunotherapy Startup 10/06/15 Texas
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy 09/18/15 National
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer 08/31/15 New York
Aveo, Still Breathing, Cuts New Deal With Novartis 08/17/15 Boston
Zoetis Gets Conditional License for Antibody Treatment of Itchy Dogs 08/05/15 Detroit Ann Arbor
La Jolla Immunology Institute Agrees to Formal Ties with UCSD 07/29/15 San Diego
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
SQZ Biotech Shifts to Therapy Development with $5M Series A 06/24/15 Boston
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit Ann Arbor
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Madison Vaccines Expands Series A To Advance Prostate Cancer Drugs 03/10/15 Wisconsin
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Cancer Agency Leaders in Houston, $111M in Grants Awarded 02/27/15 Texas
Page 1 of 3 next page »